Lung volume reduction for emphysema

The Lancet Respiratory Medicine

Volumn 5, Issue 2, 2017, Pages 147-156

  Shah, Pallav L ^a,b,c   Herth, Felix J ^d,e   van Geffen, Wouter H ^a,b,g   Deslee, Gaetan ^f   Slebos, Dirk Jan ^g  

^a ROYAL BROMPTON AND HAREFIELD NHS FOUNDATION TRUST   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c CHELSEA AND WESTMINSTER HOSPITAL NHS FOUNDATION TRUST   (United Kingdom)

^d Thoraxklinik ^*  (Germany)

^e UNIVERSITY OF HEIDELBERG   (Germany)

^f REIMS UNIVERSITY HOSPITAL   (France)

^g UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; MUSCARINIC AGENT; SCLEROSING AGENT;

ABLATION THERAPY; ARTIFICIAL VENTILATION; ATELECTASIS; BRONCHOSCOPIC THERMAL VAPOR ABLATION; BRONCHOSCOPY; CHRONIC OBSTRUCTIVE LUNG DISEASE; COILED BODY; EMPHYSEMA; EMPHYSEMATOUS LUNG SEALANT; ENDOBRONCHIAL COIL; ENDOBRONCHIAL VALVE; ENERGY; EXERCISE TOLERANCE; FORCED EXPIRATORY VOLUME; HEMOPTYSIS; HOSPITALIZATION; HUMAN; INFLAMMATION; LUNG FUNCTION; LUNG RESECTION; MEDICAL CARE; MORTALITY; NON INVASIVE SURGICAL DEVICE; PNEUMONIA; PNEUMOTHORAX; PULMONARY REHABILITATION; PULMONARY VALVE; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SCLEROTHERAPY; SIX MINUTE WALK DISTANCE; SIX MINUTE WALK TEST; THERMAL ANALYSIS; THERMAL ENERGY; TRAINING; VAPOR; LUNG; LUNG EMPHYSEMA; LUNG VENTILATION; PATHOPHYSIOLOGY; PATIENT SELECTION; PROCEDURES; TREATMENT OUTCOME;

BRONCHOSCOPY; EMPHYSEMA; HUMANS; LUNG; PATIENT SELECTION; PNEUMONECTOMY; PULMONARY EMPHYSEMA; PULMONARY VENTILATION; TREATMENT OUTCOME;

EID: 85008975685     PISSN: 22132600     EISSN: 22132619     Source Type: Journal    
DOI: 10.1016/S2213-2600(16)30221-1     Document Type: Review

References (36)

1. 1 Kemp, SV, Polkey, MI, Shah, PL, The epidemiology, etiology, clinical features, and natural history of emphysema. Thorac Surg Clin 19 (2009), 149–158.
2. 2 Global Strategy for the diagnosis, management and prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease. GOLD. http://goldcopd.org/, 2016 (accessed Sept 14, 2016).
3. 3 Brantigan, OC, Mueller, E, Surgical treatment of pulmonary emphysema. Am Surg 23 (1957), 789–804.
4. 4 Criner, GJ, Cordova, FC, Furukawa, S, et al. Prospective randomized trial comparing bilateral lung volume reduction surgery to pulmonary rehabilitation in severe chronic obstructive pulmonary disease. Am J Respir Crit Care Med 160 (1999), 2018–2027.
5. 5 Geddes, D, Davies, M, Koyama, H, et al. Effect of lung-volume-reduction surgery in patients with severe emphysema. N Engl J Med 343 (2000), 239–245.
6. 6 Goldstein, RS, Todd, TR, Guyatt, G, et al. Influence of lung volume reduction surgery (LVRS) on health related quality of life in patients with chronic obstructive pulmonary disease. Thorax 58 (2003), 405–410.
7. 7 Hillerdal, G, Lofdahl, CG, Strom, K, et al. Comparison of lung volume reduction surgery and physical training on health status and physiologic outcomes: a randomized controlled clinical trial. Chest 128 (2005), 3489–3499.
8. 8 Fishman, A, Martinez, F, Naunheim, K, et al. A randomized trial comparing lung-volume-reduction surgery with medical therapy for severe emphysema. N Engl J Med 348 (2003), 2059–2073.
9. 9 Marchetti, N, Criner, GJ, Surgical approaches to treating emphysema: lung volume reduction surgery, bullectomy, and lung transplantation. Semin Respir Crit Care Med 36 (2015), 592–608.
10. 10 Naunheim, KS, Wood, DE, Mohsenifar, Z, et al. Long-term follow-up of patients receiving lung-volume-reduction surgery versus medical therapy for severe emphysema by the National Emphysema Treatment Trial Research Group. Ann Thorac Surg 82 (2006), 431–443.
11. 11 Pompeo, E, Tacconi, F, Mineo, TC, Comparative results of non-resectional lung volume reduction performed by awake or non-awake anesthesia. Eur J Cardiothorac Surg 39 (2011), e51–e58.
12. 12 Clark, SJ, Zoumot, Z, Bamsey, O, et al. Surgical approaches for lung volume reduction in emphysema. Clin Med (Lond) 14 (2014), 122–127.
13. 13 Eberhardt, R, Gompelmann, D, Schuhmann, M, Heussel, CP, Herth, FJ, Complete unilateral vs partial bilateral endoscopic lung volume reduction in patients with bilateral lung emphysema. Chest 142 (2012), 900–908.
14. 14 Gompelmann, D, Herth, FJ, Slebos, DJ, et al. Pneumothorax following endobronchial valve therapy and its impact on clinical outcomes in severe emphysema. Respiration 87 (2014), 485–491.
15. 15 Sciurba, FC, Ernst, A, Herth, FJ, et al. A randomized study of endobronchial valves for advanced emphysema. N Engl J Med 363 (2010), 1233–1244.
16. 16 Herth, FJ, Noppen, M, Valipour, A, et al. Efficacy predictors of lung volume reduction with Zephyr valves in a European cohort. Eur Respir J 39 (2012), 1334–1342.
17. 17 Herth, FJ, Eberhardt, R, Gompelmann, D, et al. Radiological and clinical outcomes of using Chartis to plan endobronchial valve treatment. Eur Respir J 41 (2013), 302–308.
18. 18 Davey, C, Zoumot, Z, Jordan, S, et al. Bronchoscopic lung volume reduction with endobronchial valves for patients with heterogeneous emphysema and intact interlobar fissures (the BeLieVeR-HIFi study): a randomised controlled trial. Lancet 386 (2015), 1066–1073.
19. 19 Klooster, K, Ten Hacken, NH, Hartman, JE, Kerstjens, HA, van Rikxoort, EM, Slebos, DJ, Endobronchial valves for emphysema without interlobar collateral ventilation. N Engl J Med 373 (2015), 2325–2335.
20. 20 Herth, FJ, Eberhard, R, Gompelmann, D, Slebos, DJ, Ernst, A, Bronchoscopic lung volume reduction with a dedicated coil: a clinical pilot study. Ther Adv Respir Dis 4 (2010), 225–231.
21. 21 Klooster, K, Ten Hacken, NH, Franz, I, Kerstjens, HA, van Rikxoort, EM, Slebos, DJ, Lung volume reduction coil treatment in chronic obstructive pulmonary disease patients with homogeneous emphysema: a prospective feasibility trial. Respiration 88 (2014), 116–125.
22. 22 Deslee, G, Klooster, K, Hetzel, M, et al. Lung volume reduction coil treatment for patients with severe emphysema: a European multicentre trial. Thorax 69 (2014), 980–986.
23. 23 Slebos, DJ, Klooster, K, Ernst, A, Herth, FJ, Kerstjens, HA, Bronchoscopic lung volume reduction coil treatment of patients with severe heterogeneous emphysema. Chest 142 (2012), 574–582.
24. 24 Kontogianni, K, Gerovasili, V, Gompelmann, D, et al. Effectiveness of endobronchial coil treatment for lung volume reduction in patients with severe heterogeneous emphysema and bilateral incomplete fissures: a six-month follow-up. Respiration 88 (2014), 52–60.
25. 25 Shah, PL, Zoumot, Z, Singh, S, et al. Endobronchial coils for the treatment of severe emphysema with hyperinflation (RESET): a randomised controlled trial. Lancet Respir Med 1 (2013), 233–240.
26. 26 Weder, W, Tutic, M, Lardinois, D, et al. Persistent benefit from lung volume reduction surgery in patients with homogeneous emphysema. Ann Thorac Surg 87 (2009), 229–236.
27. 27 Deslee, G, Mal, H, Dutau, H, et al. Lung volume reduction coil treatment vs usual care in patients with severe emphysema: the REVOLENS randomized clinical trial. JAMA 315 (2016), 175–184.
28. 28 Sciurba, FC, Criner, GJ, Strange, C, et al. Effect of endobronchial coils vs usual care on exercise tolerance in patients with severe emphysema: the RENEW randomized clinical trial. JAMA 315 (2016), 2178–2189.
29. 29 Hartman, JE, Klooster, K, Gortzak, K, Ten Hacken, NH, Slebos, DJ, Long-term follow-up after bronchoscopic lung volume reduction treatment with coils in patients with severe emphysema. Respirology 20 (2015), 319–326.
30. 30 Zoumot, Z, Kemp, SV, Singh, S, et al. Endobronchial coils for severe emphysema are effective up to 12 months following treatment: medium term and cross-over results from a randomised controlled trial. PLoS One, 10, 2015, e0122656.
31. 31 Gompelmann, D, Eberhardt, R, Ernst, A, et al. The localized inflammatory response to bronchoscopic thermal vapor ablation. Respiration 86 (2013), 324–331.
32. 32 Herth, FJ, Valipour, A, Shah, PL, et al. Segmental volume reduction using thermal vapour ablation in patients with severe emphysema: 6-month results of the multicentre, parallel-group, open-label, randomised controlled STEP-UP trial. Lancet Respir Med 4 (2016), 185–193.
33. 33 Herth, FJ, Gompelmann, D, Stanzel, F, et al. Treatment of advanced emphysema with emphysematous lung sealant (AeriSeal(R)). Respiration 82 (2011), 36–45.
34. 34 Come, CE, Kramer, MR, Dransfield, MT, et al. A randomised trial of lung sealant versus medical therapy for advanced emphysema. Eur Respir J 46 (2015), 651–662.
35. 35 Herth, FJ, Slebos, DJ, Rabe, KF, Shah, PL, Endoscopic lung volume reduction: an expert panel recommendation. Respiration 91 (2016), 241–250.
36. 36 Bandyopadhyay, S, Henne, E, Gupta, A, et al. Segmental approach to lung volume reduction therapy for emphysema patients. Respiration 89 (2015), 76–81.